Table 1 Studies reporting hepatitis C virus (HCV) antibody incidence in Egypt.
First author, year of publication [citation] | Year(s) of data collection | Study site | Population | Sample size at recruitment | Lost to follow-up | HCV sero-conversion risk (relative to total sample size) | HCV incidence rate (per 1,000 person-years) | Total person-years | Follow-up duration (months) |
|---|---|---|---|---|---|---|---|---|---|
General population (n = 5) | |||||||||
Mohamed, 200548 | 1997–2000 | Community | Household members surveyed in Aghour el Soughra village in Nile Delta | 2,463 | 931 | — | 6.8 | 4,195 | 19 |
Mohamed, 200548 | 1997–2000 | Community | Household members surveyed in Sallam village in Upper Egypt | 4,275 | 2,443 | — | 0.8 | 6,720 | 19 |
Mostafa, 2010 49 | 2001–2006 | Community | Household members surveyed in 3 villages in Menoufia governorate in Nile Delta | 3,580 | 396 | 0.79 | 2.4 | 10,578 | 48 |
Mikhail, 200751 | 2000–2004 | Community | Control subjects surveyed in a village in Nile Delta | 149 | — | — | 10.2 | — | 10 |
Saleh, 200850 | 1997–2006 | ANC | Pregnant women surveyed in 3 villages in Menoufia governorate in Nile Delta | 2,171 | — | — | 5.2 | 4,814 | 26 |
Populations at high risk (n = 7) | |||||||||
El-Sherif, 2012166 | — | Hospital | Hemodialysis patients | 14 | — | 21.4 | — | — | 4 |
Goher, 199896 | — | Hemodialysis units | Hemodialysis patients on non-reused dialyzers | 37 | — | 21.6 | — | — | 6 |
Goher, 199896 | — | Hemodialysis units | Hemodialysis patients on reused dialyzers | 53 | — | 20.8 | — | — | 6 |
Khodir, 2012167 | 2011 | Hemodialysis units | Hemodialysis patients | 1,527 | — | 11 | — | — | 8 |
Soliman, 201392 | 2008–2010 | Hospital and hemodialysis units | Hemodialysis patients following strict isolation program | 27 | — | 14.8 | — | — | 36 |
Soliman, 201392 | 2008–2010 | Hospital and hemodialysis units | Hemodialysis patients not following strict isolation program | 56 | — | 42.9 | — | — | 36 |
Zahran, 201489 | Hemodialysis units | Hemodialysis patients | 303 | 14.5 | — | — | 36.7 | ||
Populations at intermediate risk (n = 4) | |||||||||
Abdelwahab, 201353 | 2008–2011 | Hospital | Healthcare workers | 717 | 66 | 0.3 | 2.0 | — | 18 |
Munier, 201352 | 2008–2010 | Hospital | Healthcare workers | 73 | — | 0 | — | — | 6 |
Okasha, 201554 | 2008 | Hospital | Healthcare workers | 402 | 102 | 1 | 7.3 | 551 | 18 |
Saleh, 201055 | 2000–2006 | ANC | Children of HCV infected mothers* | 2,852 | 353 | 0.53 | 2.7 | 5,573 | 66 |
Populations with liver-related conditions (n = 2) | |||||||||
Meky, 2006168 | 2002–2005 | Community | Small sub-sample of patients with liver disease biomarkers in a community study | 6 | — | 33.3 | — | — | 6 |
Mikhail, 200751 | 2000–2004 | National liver endoscopy unit | Chronic liver disease patients undergoing endoscopy | 149 | — | 2.7 | — | — | 10 |
Special clinical populations (n = 1) | |||||||||
Hassan, 201356 | — | Hospital | Stem cell transplant patients | 50 | — | 4.0 | — | — | — |
Mother-to-child transmission (n = 6) | |||||||||
Abdul-Qawi, 201057 | 2003–2008 | Hospital | Infants of HCV Ab+and RNA+mothers | 53 | — | 3.8 | — | — | 6 |
Abo Elmagd, 201161 | — | — | Infants of HCV Ab+and/or RNA+mothers | 8‡ | — | 25 | — | — | 0-12ǁ |
El-Sayed Zaki, 201362 | 2012–2013 | Hospital | Infants of HCV Ab+mothers | 12 | — | 8.3 | — | — | — |
Kassem, 200059 | 1996 | Hospital | Infants of HCV Ab+and RNA+mothers | 14 | — | 36 | — | — | 0† |
Kumar, 19958 | 1994–1996 | Hospital | Infants of HCV Ab+and RNA+mothers | 65 | — | 24.6 | — | — | 18 |
Shebl, 200960 | 1998–2001 | ANC | Infants of HCV Ab+and/or RNA+mothers | 232** | — | 3.4 | — | — | 24 |
